App-Based Mindfulness for Kidney Cancer

Palo Alto (17 mi)

Overseen bySumanta K Pal

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: N/A

Waitlist Available

Sponsor: City of Hope Medical Center

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial tests the feasibility of an application (app)-based mindfulness intervention and its effect on improving quality of life in patients with renal cell cancer that has spread to other places in the body (metastatic). This trial aims to see whether an app-based mindfulness intervention may help patients cope with their disease.

Eligibility Criteria

This trial is for patients with metastatic renal cell carcinoma who haven't practiced meditation regularly in the past year, have a significant fear of cancer progression, and have not been part of mindfulness-based recovery or stress reduction programs within 5 years. Participants must own a smartphone with internet access, be fluent in English, and currently be receiving immunotherapy.

Inclusion Criteria

I do not have major depression, bipolar, or other severe mental health issues.

My cancer has spread, confirmed by CT scans of my chest, abdomen, and pelvis.

I am currently receiving immunotherapy.

My kidney cancer diagnosis was confirmed through lab tests.

Treatment Details

The study tests an app-based mindfulness program to see if it can improve life quality for those with advanced kidney cancer. It involves using the app to engage in mindfulness exercises and completing questionnaires about their experience and feelings.

1Treatment groups

Experimental Treatment

Group I: Device feasibility (app-based mindfulness program)Experimental Treatment3 Interventions

Patients participate in a mindfulness-based program by using the Am app for 20-30 minutes every day, a minimum of 4 days each week over 4 weeks.